Business Context and Reporting Period
This Form 8-K is a current report filed by Blue Owl Capital Inc. on March 26, 2025. The filing addresses corporate governance changes, specifically the appointment of a new director to the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Board Appointment: Jennifer Brouse was appointed to the Board of Directors on March 26, 2025.
- Reason for Vacancy: The appointment fills the vacancy created by the prior resignation of Sean Ward.
- Designation Authority: Ms. Brouse was designated by the Dyal Principal Representative pursuant to the Amended and Restated Investor Rights Agreement dated August 7, 2023.
Management Commentary and Compensation
- Current Role: Ms. Brouse is currently employed by the Company as a Managing Director, Chief Operating Officer of the GP Strategic Capital platform, and a member of the GP Strategic Capital Investment Team.
- Director Compensation: No additional compensation will be paid to Ms. Brouse for her services as a director.
- Indemnification: Ms. Brouse has entered into the Company's standard indemnification agreement.
- Conflicts of Interest: The filing states Ms. Brouse has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Verify the terms of the Amended and Restated Investor Rights Agreement (Exhibit 10.2 to the 2025 Form 10-K) regarding Dyal Principal Representative designations.
- Confirm the effective date of Sean Ward's resignation to understand the timeline of the board vacancy.
- Review Ms. Brouse's existing employment agreement to ensure no conflicts arise from her dual role as an executive and a director.